Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
about
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancerHürthle cell carcinoma: current perspectivesGene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerFollicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter dataUpdate: the status of clinical trials with kinase inhibitors in thyroid cancerSurvival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experiencePrognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experienceA mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinomaThe diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genesHigh-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants.Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience.Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma.Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 casesDefective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy.Imaging, genetic testing, and biomarker assessment of follicular cell-derived thyroid cancer.Encapsulated Thyroid Carcinoma of Follicular Cell Origin.Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.Evolving molecularly targeted therapies for advanced-stage thyroid cancers.Activating BRAF Mutations Detected in Mixed Hürthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland: Report of an Unusual Case and Review of the Literature.Hürthle Cells Adenoma of the Thyroid with Post-surgical Implants in the Neck: Clinical, Morphological, and Molecular Analysis of Three Cases.Mutation profile of differentiated thyroid tumours in an Australian urban population.Differential Expression of Glycolysis-Related Proteins in Follicular Neoplasms versus Hürthle Cell Neoplasms: A Retrospective AnalysisIsolated Liver Metastasis in Hürthle Cell Thyroid Cancer Treated with Microwave Ablation.Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hurthle cell carcinoma).Do patients with oxyphilic cell papillary thyroid carcinoma have a poor prognosis? Analysis of the surveillance, epidemiology, and end results database 2004-2013 with propensity score matching.Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.Crucial parameters in thyroid carcinoma reporting - challenges, controversies and clinical implications.Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers.Identification of a novel HRAS variant and its association with papillary thyroid carcinoma.Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.Sorafenib and thyroid cancer
P2860
Q26820880-7799A57B-C1E8-4A8C-831B-A7A868D8BA33Q28069765-62EA7145-97A8-4911-B497-0887B1365C51Q30313129-5B25CB71-B709-416B-BD77-4360A8FCE914Q30367068-51ABEEDB-F199-491B-9D2F-8F3A378AAE5FQ30825440-E08F52C5-67E8-47EC-B10B-F4D86D4C9AECQ33570056-08C53B50-B02B-4F02-813C-50D0524ECD15Q33731065-ECAF0A0C-5996-4DAD-BF65-724F5008E3CAQ34422896-22878140-D4B4-4E08-A482-11D304B158E9Q35218596-FAE18215-EED6-45B2-8C9E-8CCEB7C99CFEQ35441859-5B6545FE-8FDF-4642-8542-2E0381C7968AQ35906347-A5D8242E-1D50-4351-87EB-C8E4CB65CD65Q35929824-0E25C448-E867-4FBC-A200-CC7A932E11CCQ35938064-BB764979-16D7-4290-85BA-F0C8A5670DDCQ37166289-83B78B2B-16F3-429A-AAFF-1B07909A3417Q37168074-F4279212-9CBE-4BF0-8179-F9C78F2B95F7Q37694761-21F32900-6F47-4D34-B87C-212BDBFA1A7DQ38225580-2A77D9AC-7354-4057-A968-7F69DA31D5E5Q38499954-A3FE176C-AD99-4E48-B828-42161BBD7F3AQ38677660-2A622FC5-2022-4A86-99EC-AC64AB25C86FQ38754489-A736B128-CEB1-47E6-92DA-C17A3C3D5958Q38785849-263DADD1-6BF2-43CA-8BD5-D1D20E0D43D5Q38815937-16D54610-01BB-41BC-AA49-23394EC8A76BQ40195630-8B4D44D4-52DE-4D3B-BBA5-4EA6312E5590Q41169131-12587FF3-9123-480D-B7D1-B4B9F7BF259DQ42008779-703FAD3C-342C-4B7B-8188-AF7A19CD7A56Q47128939-704D5F5E-0124-4CDC-9C14-7DB387E888C6Q47141613-98C50D49-7E7E-40B0-B2F5-B08D2DC0949BQ47295202-730E9D70-D9F3-4E2F-8415-4B4277BD270BQ48283721-4CD4F625-C3E6-40EC-BBE0-62CCBCC15498Q52609129-6C8A54AB-200E-4BDC-9A36-7F1E3136ED5DQ52647717-96FC38EA-DAD8-4266-A744-4384D7BEB125Q54375513-19A88BF4-430A-4E6D-8876-F5975B2A2236Q56504638-8D751523-DAEB-45E3-B503-5676B3FFEE40
P2860
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
@ast
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
@en
Genomic dissection of Hurthle ...... e class of thyroid malignancy.
@nl
type
label
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
@ast
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
@en
Genomic dissection of Hurthle ...... e class of thyroid malignancy.
@nl
prefLabel
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
@ast
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
@en
Genomic dissection of Hurthle ...... e class of thyroid malignancy.
@nl
P2093
P2860
P356
P1476
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy
@en
P2093
James A Fagin
Julio Ricarte Filho
Luc G T Morris
Nicholas Socci
Qianxing Mo
Ronald Ghossein
Stephanie Eng
Timothy A Chan
Yupu Liang
P2860
P304
P356
10.1210/JC.2012-3539
P407
P577
2013-03-29T00:00:00Z